Emanuela Izzo

Company: BioMarin Pharmaceutical

Job title: Director CDx development

Seminars:

Application of a Total Antibody (TAb) Assay as a Companion Diagnostic (CDx) for AAV5 Gene Therapy 2:30 pm

Rationale for the selection of a Companion Diagnostic (CDx) for AAV5-based gene therapy for the treatment of Hemophilia A Validation of the AAV5 TAb assay as a companion diagnostic according to international standard and regulatory requirements AAV5 TAb CDx commercialization effort to ensure patients access to the validated and approved testRead more

day: Conference Day Two - Track 2 - PM

Panel Discussion: Building a Better Dynamic Between Biopharma & Diagnostics Developer to Deliver Drugs to Patients Faster 12:30 pm

How are regulations impacting CDx and assay manufacturers? How are they impacting biopharma? What are the performance limitations of current instruments and assays used/needed routinely by biopharma? What are the cultural differences between biopharma and diagnostics developers? How do you manage this from a biopharma perspective? In what ways can we be improving co-development relationship?Read more

day: Conference Day One - Track 2